39 research outputs found

    Expression of <i>Tbx4</i> and <i>Tbx5</i> in the developing lung and trachea.

    No full text
    <p>(A–L) <i>Tbx4</i> and <i>Tbx5</i> expression analyzed using ISH on lungs. <i>Tbx5</i> is first expressed at E9.0 (B,D) when the specification of lung primordia occurs, as seen by <i>Nkx2.1</i> expression (A,C). Red arrows point to the posterior extent of the third pharyngeal pouch which marks the anterior of the expression domain of both <i>Nkx2.1</i> and <i>Tbx5</i>. Right views (A,B), ventral views (C,D). <i>Tbx4</i> is first expressed at E9.5 along with <i>Tbx5</i> in the newly formed lung buds (E,F). Expression is seen in lung whole mounts at E11.5 (G,H), E13.5 (I,J) and in lung mesenchyme in cryosections at E15.5 (K,L). (M–S) <i>Tbx4</i> and <i>Tbx5</i> expression analyzed using ISH on tracheas. <i>Tbx4</i> and <i>Tbx5</i> are expressed throughout tracheal mesenchyme (m) at E13.5 (M,M′,N,N′) but not in the epithelium (e) or the mesothelium (arrowheads). Caudal view of cut tracheas after whole mount ISH (M–P). ISH on cryosections (M′–P′). At E13.5, <i>Sox9</i> is expressed in the mesenchyme on the ventral side (O,O′) and <i>SM22α</i> is expressed on the dorsal side (P,P′) of the trachea. D-dorsal; V-ventral; R-right; L-left. At E15.5, <i>Tbx4</i> and <i>Tbx5</i> are expressed around the condensing cartilage mesenchyme and in the intercartilage mesenchyme (Q,R). <i>Sox9</i> is expressed in the condensing cartilage rings (S). Asterisks indicate areas of cartilage condensation. Insets in (Q) and (S) show ISH on E15.5 sagittal cryosections with <i>Tbx4</i> and <i>Sox9</i> probe, respectively. Scale bars represent 50 µm.</p

    Early loss of <i>Tbx5</i> leads to aberrant lung bud and trachea specification.

    No full text
    <p>(A–I) Foreguts were isolated between 8–16 somite stages and analyzed by ISH following culture. <i>Nkx2.1</i> (A), <i>Tbx4</i> (B) and <i>Tbx5</i> (C) expression in lung buds (arrows) and tracheal primordia (yellow arrowhead) was confirmed in control cultures. Excision of <i>Tbx5</i> using 4-OH tamoxifen in conditional null foreguts with <i>CreER</i> leads to the loss of <i>Nkx2.1</i> expression in one of the lung buds at 3 (E) or 4 days (H). Conditional double nulls (F,I) carrying <i>CreER</i> show a phenotype similar to the conditional <i>Tbx5</i> nulls, suggesting additional removal of <i>Tbx4</i> does not exacerbate the phenotype. <i>Nkx2.1</i> expression was absent in the foregut tube of conditional <i>Tbx5</i> null and conditional double null foreguts after 3 or 4 days of culture (yellow arrowheads in E,F,H,I) compared to controls (D,G). Conditional <i>Tbx5</i> nulls show reduced <i>Wnt2</i> expression (K) and absence of <i>Wnt2b</i> expression (M) in the developing lung buds as compared to controls (J,L). Black arrowheads (J) point to <i>Wnt2</i> expression in the heart in the controls. ht, heart; th, thyroid primordia.</p

    Multiple Roles and Interactions of <em>Tbx4</em> and <em>Tbx5</em> in Development of the Respiratory System

    Get PDF
    <div><p>Normal development of the respiratory system is essential for survival and is regulated by multiple genes and signaling pathways. Both <em>Tbx4</em> and <em>Tbx5</em> are expressed throughout the mesenchyme of the developing lung and trachea; and, although multiple genes are known to be required in the epithelium, only Fgfs have been well studied in the mesenchyme. In this study, we investigated the roles of <em>Tbx4</em> and <em>Tbx5</em> in lung and trachea development using conditional mutant alleles and two different Cre recombinase transgenic lines. Loss of <em>Tbx5</em> leads to a unilateral loss of lung bud specification and absence of tracheal specification in organ culture. Mutants deficient in <em>Tbx4</em> and <em>Tbx5</em> show severely reduced lung branching at mid-gestation. Concordant with this defect, the expression of mesenchymal markers <em>Wnt2</em> and <em>Fgf10</em>, as well as Fgf10 target genes <em>Bmp4</em> and <em>Spry2</em>, in the epithelium is downregulated. Lung branching undergoes arrest <em>ex vivo</em> when <em>Tbx4</em> and <em>Tbx5</em> are both completely lacking. Lung-specific <em>Tbx4</em> heterozygous;<em>Tbx5</em> conditional null mice die soon after birth due to respiratory distress. These pups have small lungs and show severe disruptions in tracheal/bronchial cartilage rings. <em>Sox9</em>, a master regulator of cartilage formation, is expressed in the trachea; but mesenchymal cells fail to condense and consequently do not develop cartilage normally at birth. <em>Tbx4</em>;<em>Tbx5</em> double heterozygous mutants show decreased lung branching and fewer tracheal cartilage rings, suggesting a genetic interaction. Finally, we show that <em>Tbx4</em> and <em>Tbx5</em> interact with <em>Fgf10</em> during the process of lung growth and branching but not during tracheal/bronchial cartilage development.</p> </div

    Loss of <i>Tbx4</i> and <i>Tbx5</i> affects the <i>Fgf10</i> signaling pathway and <i>Wnt2</i> expression.

    No full text
    <p>(A–X) Marker analysis of control and <i>Tbx4</i>- and <i>Tbx5</i>-deficient lungs using whole mount ISH (A–O, S–X) and IHC (P–R): Fewer foci of <i>Fgf10</i> expression were seen in the <i>Tbx4</i> and <i>Tbx5</i>-deficient lungs (B,C) compared to control (A). cr, cranial; m, medial; cd, caudal; a, accesory lobes. Fgf10 target genes <i>Bmp4</i> (F,G,H) and <i>Spry2</i> (I,J) and canonical <i>Wnt2</i> (K,L,M) were downregulated in <i>Tbx4</i> and <i>Tbx5</i>-deficient lungs compared to controls. <i>Fgfr2</i> (D,E), <i>Etv5</i> (N,O), PECAM (P,Q,R), <i>Shh</i> (S,T), <i>Ptc</i> (U,V) and <i>Nkx2.1</i> (W,X) were expressed similarly in controls and <i>Tbx4</i> and <i>Tbx5</i>-deficient lungs.</p
    corecore